Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
about
A comprehensive review on pharmacotherapeutics of herbal bioenhancersInteractions between CYP3A4 and Dietary PolyphenolsP-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A reviewHerbal-drug interaction induced rhabdomyolysis in a liposarcoma patient receiving trabectedin.Pharmacokinetics of artemisinin delivered by oral consumption of Artemisia annua dried leaves in healthy vs. Plasmodium chabaudi-infected miceQuercetin significantly inhibits the metabolism of caffeine, a substrate of cytochrome P450 1A2 unrelated to CYP1A2*1C (-2964G>A) and *1F (734C>A) gene polymorphisms.12-lipoxygenase: a potential target for novel anti-platelet therapeutics.A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection.Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening.Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro.Metabolic map and bioactivation of the anti-tumour drug noscapine.Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in ratsNovel insights into the pharmacology of flavonoids.Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.Excipient foods: designing food matrices that improve the oral bioavailability of pharmaceuticals and nutraceuticals.Interference of flavonoids with fluorescent intracellular probes: methodological implications in the evaluation of the oxidative burst by flow cytometry.Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.Flavonoids as modulators of metabolic enzymes and drug transporters.Herb-Drug Pharmacokinetic Interactions: Transport and Metabolism of Indinavir in the Presence of Selected Herbal Products.Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.Natural Polyphenols in Cancer Chemoresistance.Molecular mechanisms of action of quercetin in cancer: recent advances.Gastrointestinal interactions, absorption, splanchnic metabolism and pharmacokinetics of orally ingested phenolic compounds.Artemisinin permeability via Caco-2 cells increases after simulated digestion of Artemisia annua leaves.Studies on Pharmacokinetic Drug Interaction Potential of VinpocetineSevere Rhabdomyolysis during Treatment with Trabectedin in Combination with a Herbal Drug in a Patient with Metastatic Synovial Sarcoma: A Case Report.Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative.Effect of quercetin on P-glycoprotein transport ability in Chinese healthy subjects.Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative.Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis.Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats.Getting Drugs Across Biological Barriers.Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress.Effects of 17α-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin.Toxicokinetics and toxicodynamics of chlorpyrifos is altered in embryos of Japanese medaka exposed to oil sands process-affected water: evidence for inhibition of P-glycoprotein."Drugs on oxygen": an update and perspective on the role of cytochrome P450 testing in pharmacology.The protective effects of naringin against 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats.Effects of morin on the pharmacokinetics of docetaxel in rats with 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorsSimultaneous Quantification of Glibenclamide, Simvastatin, and Quercetin by Using LC-UV Method and Its Application to Pharmacokinetic Study in Rats
P2860
Q24633680-AFFBD91A-EC9C-4E60-AB61-199BF1382ED8Q26800893-E2C078A3-D1E1-4FC2-BFE8-BB6363049779Q27024260-15BEEBD7-C879-490A-A062-9578DDD88724Q31124946-D9ADC014-4037-43D7-863C-E922AE8B6683Q33606617-22780F24-E8CB-4D21-95FF-BACEA3345613Q33849856-94DDBB45-CF6A-4876-9611-B8058F57F359Q34207687-F154A57A-B73B-4B21-AEDD-4A57FB095A85Q35389260-CCFA0784-6720-4AE5-AB99-8197810BF532Q35801869-A72A76F6-3FAA-47CC-8BC0-B9E2AE08E3F9Q35873088-BFD50AA9-5532-4C3F-A710-25D67859BAE1Q36419303-6FBE27FA-CA1D-4AD4-8399-CB92FA4F5AC4Q37297477-D529A742-AE4A-4A75-B142-363D7143E364Q38119186-BE3F0173-4328-4561-AED3-633B8896D699Q38167822-3B890491-B1D3-4D77-A16B-3E88686880E5Q38206716-50D166F0-FE48-4EDC-BA7B-111116448D02Q38216941-8349B356-1D61-43F1-9F5E-F49BB3D69934Q38581733-65AA8E92-95E0-413E-9AAD-5E5D3EA6FF5BQ38717216-AAE29DE0-B1AE-4FDD-927F-753C83CBCE74Q38810007-C8EB8353-7E05-4325-A74B-3ED5B49048CDQ38856533-86BB4658-1260-4C05-8E9F-E325BBEC4378Q38883165-1493B866-A301-4062-9E6F-280C43FF2FE3Q38905686-CB34E977-1FDA-40EE-8879-3793E7937A10Q39079382-86FC8C04-ADF4-426D-A59C-650AB010A296Q40040962-1567F358-36B8-44CC-9315-28EE318AF1E9Q41167581-E01A7962-0BD1-454A-86E7-0A65F0BAE6D4Q42283569-0C580E27-B9CD-47B4-9402-783862CA09B2Q42366841-37A756F5-24E6-4D85-B03F-CD5FDE6734AAQ42688103-FC83BEEC-925C-4799-81F2-6B6A86E88BFEQ45233264-FC8DC29C-0C0D-4FD2-ACD1-2B70B0834DA2Q46373476-3C32D77C-4757-46C2-B0D5-1CAB58C8C1DBQ47228271-F72F55CC-66B5-406D-B1CF-2AD8F1D1CF26Q47851974-10331A68-1E60-421B-AF8E-520F1081B4EAQ48331228-259875C6-EF53-4834-B348-D97A6EFA96D0Q50891748-C8325BA2-85E9-4DCD-8096-8B01A15C2057Q51076455-271EC4D1-FDA3-40F8-8308-75BED1CED9DFQ51367359-C4CF2CB9-268A-445E-A67C-7EC3B93AFB27Q51557998-613FA55F-5D4F-4EC3-B165-9570050918E1Q54990196-936780A9-1A40-4C77-A109-B5AD655DD3DAQ58854619-5B6E2DFD-8334-4F7A-AF23-BE3779E2CDCFQ58920851-E5BEFCA3-119A-4331-8592-6084FA585731
P2860
Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effects of quercetin on the bi ...... P-gp inhibition by quercetin.
@en
Effects of quercetin on the bi ...... P-gp inhibition by quercetin.
@nl
type
label
Effects of quercetin on the bi ...... P-gp inhibition by quercetin.
@en
Effects of quercetin on the bi ...... P-gp inhibition by quercetin.
@nl
prefLabel
Effects of quercetin on the bi ...... P-gp inhibition by quercetin.
@en
Effects of quercetin on the bi ...... P-gp inhibition by quercetin.
@nl
P2093
P2860
P1476
Effects of quercetin on the bi ...... P-gp inhibition by quercetin.
@en
P2093
Jun-Shik Choi
Keon Wook Kang
Yong-Ji Piao
P2860
P2888
P304
P356
10.1007/S12272-011-0411-X
P577
2011-04-01T00:00:00Z